Health
No benefit from virus blood plasma: study – The West Australian
A trial looking at whether blood plasma from COVID-19 patients can help those who are seriously ill does not appear to work in ICU patients, researchers say.
An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit, trial investigators say.
The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product – an antibody-rich plasma taken from people who have recovered from the pandemic…
-
Noosa News17 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General24 hours agoMinecraft mayhem: ‘Chicken jockey’ chaos reaches Australian cinemas
-
General16 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General18 hours agoCanberra man named as doctor accused of rape after suppression order lifted